These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 7200956

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination.
    Rabquer B, Smithson SL, Shriner A, Julie Westerink MA.
    Immunol Lett; 2006 Aug 15; 106(2):187-90. PubMed ID: 16781780
    [Abstract] [Full Text] [Related]

  • 24. Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates.
    Safari D, Dekker HA, Rijkers G, Snippe H.
    Vaccine; 2011 Jan 17; 29(4):849-54. PubMed ID: 21111776
    [Abstract] [Full Text] [Related]

  • 25. Antibody response to pneumococcal polysaccharide vaccine in young, adult and old mice.
    Aaberge IS, North RJ, Groeng EC, Løvik M.
    Scand J Immunol; 1993 Jul 17; 38(1):17-30. PubMed ID: 8327857
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. IgG2 subclass restriction of antibody to pneumococcal polysaccharides.
    Barrett DJ, Ayoub EM.
    Clin Exp Immunol; 1986 Jan 17; 63(1):127-34. PubMed ID: 3955880
    [Abstract] [Full Text] [Related]

  • 29. Kinetics of the antibody response to type III pneumococcal polysaccharide. II. Factors influencing the serum antibody levels after immunization with an optimally immunogenic dose of antigen.
    Jones JM, Amsbaugh DF, Prescott B.
    J Immunol; 1976 Jan 17; 116(1):52-64. PubMed ID: 1446
    [Abstract] [Full Text] [Related]

  • 30. Altered response to pneumococcal polysaccharide in offspring of immunologically paralyzed mice.
    Kerman R, Segre D, Myers WL.
    Science; 1967 Jun 16; 156(3781):1514-6. PubMed ID: 4388423
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pneumococcal polysaccharide immunization of children with sickle cell disease. II. Serologic response and pneumococcal disease following immunization.
    Overturf GD, Selzer JW, Chan L, Weiss J, Field R, Rigau-Perez JG, Powars D, Uy C, Pang EJ, Honig G, Steele R, Edmonds R, Portnoy B.
    Am J Pediatr Hematol Oncol; 1982 Jun 16; 4(1):25-35. PubMed ID: 7091574
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H, Peng Y, Lin Z, Zhang S, Guo Y.
    Microb Pathog; 2015 Jun 16; 83-84():35-40. PubMed ID: 25959527
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of antibody responses to pneumococcal vaccines with ELISA and opsonophagocytic assay.
    Kim KH, Seoh JY.
    J Korean Med Sci; 1999 Oct 16; 14(5):475-9. PubMed ID: 10576141
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide.
    Paton JC, Lock RA, Lee CJ, Li JP, Berry AM, Mitchell TJ, Andrew PW, Hansman D, Boulnois GJ.
    Infect Immun; 1991 Jul 16; 59(7):2297-304. PubMed ID: 2050399
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.